RA Capital Management, L.P. 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:43 pm Purchase | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | RA Capital Management, L.P. | 11,520,120 9.900% | 1,047,745 (+10.00%) | Filing |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | RA Capital Management, L.P. | 10,472,375 9.990% | 7,000,269 (+201.61%) | Filing |
| 2024-02-14 6:41 pm Purchase | 2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | RA Capital Management, L.P. | 3,472,106 9.990% | 1,417 (+0.04%) | Filing |
| 2023-07-06 4:30 pm Purchase | 2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY | RA Capital Management, L.P. | 3,470,689 9.990% | 3,470,689 (New Position) | Filing |